A novel probiotic, Lactobacillus johnsonii 456, resists acid and can persist in the human gut beyond the initial ingestion period
- 2018-12-22
- Clinical Trial
- Gut Microbes 10(4)
- Michael J Davoren
- Jared Liu
- Jocelyn Castellanos
- Norma I Rodríguez-Malavé
- R. Schiestl
- PubMed: 30580660
- DOI: 10.1080/19490976.2018.1547612
- High evidence
LBJ 456 also altered pathogen adhesion to LS 174T monolayers and demonstrated contact-dependent and independent inhibition of pathogen growth.
- Effect
- Beneficial
- Effect size
- Moderate